Histone deacetylase (HDAC) inhibitors are a class of drugs used in the cancer treatment. Here, we developed library 19 analogues Vorinostat, an HDAC inhibitor lymphomas In replaced hydrophobic phenyl group with various tricyclic ‘caps’ possessing central, eight-membered, heterocyclic ring, and investigated activity cytotoxic effect on normal cell lines. We found that 3 out compounds, based dibe...

objective(s): t-cell acute lymphoblastic leukemia (t-all) is an aggressive hematologic malignant tumor. administration of chemical compounds influencing apoptosis and t cell development has been discussed as promising novel therapeutic strategies. valproic acid (vpa) as a recently emerged anti-neoplastic histone deacetylase (hdac) inhibitor and pioglitazone (pgz) as a high-affinity peroxisome p...

Multiple myeloma (MM) is incurable cancer in the blood system. Magnolol an effective component against various cancers. This study tried to investigate effect and mechanism of magnolol on MM via regulating miR-129. Human normal plasma cells (nPCs) U266 LP1 were used this study, accompanied by treatment magnolol. The miR-129 inhibitor was transfected into during experiments. Cell viability detec...

The replication licensing factor (RLF) is an essential initiation factor that is involved in preventing re-replication of chromosomal DNA in a single cell cycle. In Xenopus egg extracts, it can be separated into two components: RLF-M, a complex of MCM/P1 polypeptides, and RLF-B, which is currently unpurified. In this paper we investigate variations in RLF activity throughout the cell cycle. Tot...

PI3Kδ is predominately expressed in leukocytes and has been found overexpressed in B-cell related malignances such as CLL and AML. We have discovered a highly selective ATP competitive PI3Kd inhibitor PI3KD-IN-015, which exhibits a high selectivity among other PI3K isoforms in both biochemical assays and cellular assay, meanwhile did not inhibit most of other protein kinases in the kinome. PI3K...

The B cell is a vital contributor to humoral immunity. The B cell-specific antigen CD20 is expressed during B cell development, starting at the pre-B cell level and persists through B cell differentiation, but is lost during terminal differentiation to plasma cells. Rituximab is a monoclonal antibody that destroys both normal and malignant B cells that have CD20 on their surfaces and is ther...

There is a vital role of B cells in the pathogenesis Systemic Lupus Erythematosus (SLE). Belimumab (Bel), an inhibitor cell activating factor (BAFF), and Rituximab (RTX), monoclonal antibody targeting Cd20 antigen, have been used to manage systemic lupus. Several randomized controlled trials (RCTs) evaluated these two agents' clinical efficacy safety different manifestations SLE. This study aim...